SCHEMBL6877409

SCHEMBL6877409

CCc1ccccc1NC(=O)N[C@H]1CC[C@@H](Nc2nccc(N(C)C)n2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.56
PKM P14618 1/20 0.43
MCHR1 Q99705 6/20 0.42
MAPK14 Q16539 3/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C19 P33261 1/20 0.41
MAPK8 P45983 2/20 0.41
AURKB Q96GD4 1/20 0.41
KDR P35968 1/20 0.40
MEN1 O00255 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CYP2C9 P11712 1/20 0.40
CCNE1 P24864 1/20 0.40
CDK2 P24941 1/20 0.40
MAPK9 P45984 1/20 0.40
MAPK10 P53779 1/20 0.40
ADRA2A P08913 1/20 0.39
ADRA1A P35348 1/20 0.39
HRH1 P35367 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6877414 1.00 KMT2A (0.56) KMT2APKMMCHR1MAPK14CYP2D6
SCHEMBL6872291 0.93 KMT2A (0.47) KMT2APKMMCHR1MAPK14MAPK8
SCHEMBL6872289 0.93 KMT2A (0.47) KMT2APKMMCHR1MAPK14MAPK8
SCHEMBL6867565 0.89 KMT2A (0.44) KMT2AMCHR1MAPK14CYP2D6MAPK8
SCHEMBL6867558 0.89 KMT2A (0.44) KMT2AMCHR1MAPK14CYP2D6MAPK8
SCHEMBL6877104 0.89 MCHR1 (0.43) KMT2AMCHR1MAPK8AURKBKDR
SCHEMBL6877107 0.89 MCHR1 (0.43) KMT2AMCHR1MAPK8AURKBKDR
SCHEMBL6875360 0.89 MCHR1 (0.43) KMT2AMCHR1MAPK14MAPK8MEN1
SCHEMBL6875353 0.89 MCHR1 (0.43) KMT2AMCHR1MAPK14MAPK8MEN1
SCHEMBL6872847 0.88 EPHX2 (0.47) KMT2AMCHR1MAPK14MAPK8AURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1464335-A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist Taisho Pharmaceutical Co. Ltd. (JP) 2004-10-06 EP disclosed